A Randomized, Double-Blind, Parallel Group Trial Comparing 12 Weeks Treatment With Tiotropium 18 Mcg Daily to Combivent MDI 2 Actuations Qid in COPD Patients Previously Prescribed Combivent MDI.
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2014
At a glance
- Drugs Tiotropium bromide (Primary) ; Ipratropium-bromide/salbutamol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 14 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 31 Jan 2008 Status change from recruiting to in progress.
- 09 Nov 2006 New trial record.